advertisement

Topcon

Azuara-Blanco A 10

Showing records 1 to 10 | Display all abstracts from Azuara-Blanco A

99376 Home-based Perimetry for Glaucoma: Where are We Now?
Daka Q
Journal of Glaucoma 2022; 31: 361-374
99062 Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Mouhammad ZA; Vohra R
Frontiers in neuroscience 2022; 16: 824054
99376 Home-based Perimetry for Glaucoma: Where are We Now?
Mustafa R
Journal of Glaucoma 2022; 31: 361-374
99062 Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Horwitz A
Frontiers in neuroscience 2022; 16: 824054
99376 Home-based Perimetry for Glaucoma: Where are We Now?
Neziri B
Journal of Glaucoma 2022; 31: 361-374
99062 Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Thein AS
Frontiers in neuroscience 2022; 16: 824054
99376 Home-based Perimetry for Glaucoma: Where are We Now?
Virgili G
Journal of Glaucoma 2022; 31: 361-374
99062 Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Rovelt J
Frontiers in neuroscience 2022; 16: 824054
99376 Home-based Perimetry for Glaucoma: Where are We Now?
Azuara-Blanco A
Journal of Glaucoma 2022; 31: 361-374
99062 Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Cvenkel B; Williams PA; Azuara-Blanco A; Kolko M
Frontiers in neuroscience 2022; 16: 824054

Issue 22-4

Change Issue


advertisement

WGA Rescources